Literature DB >> 16249649

Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003.

Dayse Pereira Campos1, Sayonara Rocha Ribeiro, Beatriz Grinsztejn, Valdiléa G Veloso, Joaquim Gonçalves Valente, Francisco Inácio Bastos, Mariza Gonçalves Morgado, Angela Jourdan Gadelha.   

Abstract

BACKGROUND: Recent studies have shown substantial increases in the survival of AIDS patients in developed countries and in Brazil as a result of antiretroviral therapy (ART) and prophylaxis for opportunistic infections. This study compares survival rates using the Brazilian Ministry of Health 2004 and Centers for Disease Control and Prevention (CDC) 1993 case definitions in a large HIV/AIDS referral centre in Rio de Janeiro.
METHODS: Survival after AIDS diagnosis was assessed in a clinic-based cohort of 1415 individuals using the Kaplan-Meier method and Cox proportional hazards models.
RESULTS: There were 393 (88%) deaths from AIDS-related causes and 52 (12%) from unrelated or unknown causes. A total of 205 patients (14%) were lost to follow-up and 765 patients (55%) remained alive until the end of the study. Three-quarters of patients (75%) were still alive 22 months [95% confidence interval (CI) 19-26] after the AIDS diagnosis according to the CDC case definition and 31 months (95% CI 26-36) according to the Ministry of Health case definition. Independent predictors of survival included AIDS defined by CD4 cell count and any use of highly active antiretroviral therapy, with either case definition, and initial stage of the case, with the Ministry of Health case definition.
CONCLUSION: Survival observed in this reference centre is comparable or longer than other international studies, although the choice of case definition criterion influenced findings. Adoption of the Ministry of Health case definition may enhance the ability to track the use of and outcomes from ART among AIDS patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249649     DOI: 10.1097/01.aids.0000191486.92285.1c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

Review 1.  Economic evaluation of ART in resource-limited countries.

Authors:  Sandrine Loubiere; Constance Meiners; Caroline Sloan; Kenneth A Freedberg; Yazdan Yazdanpanah
Journal:  Curr Opin HIV AIDS       Date:  2010-05       Impact factor: 4.283

2.  Early mortality and cause of deaths in patients using HAART in Brazil and the United States.

Authors:  Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

3.  Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil.

Authors:  A Nunn; E Da Fonseca; S Gruskin
Journal:  Glob Public Health       Date:  2009

4.  Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil.

Authors:  Angela Cristina Vasconcelos de Andrade; Paula Mendes Luz; Luciane Velasque; Valdiléa Gonçalves Veloso; Ronaldo I Moreira; Fabio Russomano; Janice Chicarino-Coelho; Elaine Pires; José Eduardo Levi; Beatriz Grinsztejn; Ruth Khalili Friedman
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

5.  Late entry into HIV care: estimated impact on AIDS mortality rates in Brazil, 2003-2006.

Authors:  Alexandre Grangeiro; Maria Mercedes Escuder; Paulo Rossi Menezes; Rosa Alencar; Euclides Ayres de Castilho
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

6.  Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007.

Authors:  Monica Alonso Gonzalez; Luise Martin; Sergio Munoz; Jerry O Jacobson
Journal:  BMC Public Health       Date:  2011-07-29       Impact factor: 3.295

7.  Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

Authors:  Amy S Nunn; Elize M Fonseca; Francisco I Bastos; Sofia Gruskin; Joshua A Salomon
Journal:  PLoS Med       Date:  2007-11-13       Impact factor: 11.069

8.  The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women.

Authors:  Oliver Chukwujekwu Ezechi; Per Olof Ostergren; Francisca Obiageri Nwaokorie; Innocent Achaya Otobo Ujah; Karen Odberg Pettersson
Journal:  Virol J       Date:  2014-01-15       Impact factor: 4.099

9.  Individual and contextual factors of influence on adherence to antiretrovirals among people attending public clinics in Rio de Janeiro, Brazil.

Authors:  Homaira Hanif; Francisco I Bastos; Monica Malta; Neilane Bertoni; Pamela J Surkan; Peter J Winch; Deanna Kerrigan
Journal:  BMC Public Health       Date:  2013-06-13       Impact factor: 3.295

10.  Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.

Authors:  Sandra W Cardoso; Paula M Luz; Luciane Velasque; Thiago Torres; Lara Coelho; Kenneth A Freedberg; Valdilea G Veloso; Rochelle P Walensky; Beatriz Grinsztejn
Journal:  AIDS Res Ther       Date:  2014-09-01       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.